Primary care treatment of attention-deficit/hyperactivity disorder

Journal of Clinical Psychiatry

Volumn 67, Issue SUPPL. 8, 2006, Pages 51-58

  Culpepper, Larry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL; TRICYCLIC ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; PROPYLAMINE;

ANOREXIA; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONSTIPATION; DRUG MECHANISM; DRUG TOLERABILITY; FAMILY RELATION; HEADACHE; HEALTH EDUCATION; HUMAN; INSOMNIA; MEDICAL ASSESSMENT; MENTAL HEALTH; PATIENT EDUCATION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOCIAL PSYCHOLOGY; STOMACH PAIN; TIC; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA; ADULT; AGE; ATTITUDE TO HEALTH; CHILD; FAMILY HEALTH; GENERAL PRACTITIONER; HUMAN RELATION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PARENT; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; TEACHING;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; BUPROPION; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; COMORBIDITY; FAMILY HEALTH; HUMANS; PARENTS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; PROFESSIONAL-FAMILY RELATIONS; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; TEACHING;

EID: 33748643185     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Arnsten AFT. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 2006;67(suppl 8):7-12
2. Faraone SV, Khan SA. Candidate gene studies of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 2006;67(suppl 8):13-20
3. Neuman RJ, Heath A, Reich W, et al. Latent class analysis of ADHD and comorbid symptoms in a population sample of adolescent female twins. J Child Psychol Psychiatry 2001;42:933-942
4. Volk HE, Neuman RJ, Todd RD. A systematic evaluation of ADHD and comorbid psychopathology in a population-based twin sample. J Am Acad Child Adolesc Psychiatry 2005;44:768-775
5. Bobb AJ, Castellanos FX, Addington AM, et al. Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet B Neuropsychiatr Genet 2005;132:109-125
6. Linnet KM, Dalsgaard S, Obel C, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003;160:1028-1040
7. Lahey BB, Pelham WE, Loney J, et al. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry 2004;161:2014-2020
8. Biederman J, Kwon A, Aleardi M, et al. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am J Psychiatry 2005;162:1083-1089
9. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627
10. Brown RT, Freeman WS, Perrin JM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 2001;107:E43
11. Byrne JM, Bawden HN, Beattie TL, et al. Preschoolers classified as having attention-deficit hyperactivity disorder (ADHD): DSM-IV symptom endorsement pattern. J Child Neurol 2000;15:533-538
12. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:711-726
13. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics 2005;115:1734-1746
14. Schulz KP, Fan J, Tang CY, et al. Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study. Am J Psychiatry 2004;161:1650-1657
15. McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004;161:1948-1956
16. Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289
17. Roy-Byrne P, Scheele L, Brinkley J, et al. Adult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic. Compr Psychiatry 1997;38:133-140
18. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94
19. Ossmann JM, Mulligan NW. Inhibition and attention deficit hyperactivity disorder in adults. Am J Psychol 2003;116:35-50
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: Primary Care Version (DSM-IV-PC). Washington, DC: American Psychiatric Association; 1994
21. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-1170
22. Mitsis EM, McKay KE, Schulz KP, et al. Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 2000;39:308-313
23. Smith BH, Pelham WE Jr, Gnagy E, et al. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2000;68:489-499
24. Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry 2004;65(suppl 3):12-17
25. Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. New York, NY: Oxford University Press; 1995
26. Biederman J, Faraone SV, Knee D, et al. Retrospective assessment of DSM-III attention deficit disorder in nonreferred individuals. J Clin Psychiatry 1990;51:102-106
27. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-1798
28. Bird HR, Gould MS, Staghezza BM. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry 1993;32:361-368
29. Biederman J. Impact of comorbidity in adults with attention-deficit/ hyperactivity disorder. J Clin Psychiatry 2004;65(suppl 3):3-7
30. Wilens TE. Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry 2004;65(suppl 3):38-45
31. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? a meta-analytic review of the literature. Pediatrics 2003;111:179-185
32. DeLong R. Medical and pharmacologic treatment of learning disabilities. J Child Neurol 1995;10(suppl 1):S92-S95
33. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991;148:564-577
34. American Academy of Pediatrics. Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/ Hyperactivity Disorder. Pediatrics 2001;108:1033-1044
35. Stevenson RD, Wolraich ML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am 1989;36:1183-1197
36. Greenhill LL. Attention-deficit hyperactivity disorder: the stimulants. Child Adolesc Psychiatr Clin North Am 1995;4:123-168
37. Pelham WE, Burrows-Maclean L, Gnagy EM, et al. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol 2005;13:111-126
38. Pelham WE Jr, Manos MH, Ezzell CE, et al. A dose-ranging study of methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005;44:522-529
39. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 1996;35:264-272
40. Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry 2006;67:137-147
41. Biederman J, Swanson JM, Wigal B, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/ hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible dose study. Pediatrics 2005;116:777-784
42. Stahl SM. Essential Psychopharmacology. New York, NY; Cambridge University Press; 1996
43. Spencer TJ, Biederman J, Wilens TE, et al. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 2002;63 (suppl 12):17-22
44. Conners CK, Casat CD, Gualtieri CT, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1996;35:1314-1321
45. Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2001;21:223-228
46. Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry 2004;65(suppl 3):27-37
47. Weiss MD, Gadow K, Wasdell MB. Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67(suppl 8):38-45
48. Safren SA. Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 2006;67(suppl 8):46-50